Felix C. Saalfeld

Dresden, SN 01307, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Palliative Systemic Therapy in Advanced Thymic Epithelial Tumors in 2026-A Narrative Review.

Palliative Systemic Therapy in Advanced Thymic Epithelial Tumors in 2026-A Narrative Review.

Journal: Cancers

Published: June 05, 2026

Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.

Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.

Journal: Clinical lung cancer

Published: March 26, 2026

Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications.

Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications.

Journal: Leukemia

Published: October 16, 2025

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

Journal: NPJ precision oncology

Published: September 05, 2025

Histologic Transformation in Cancer: The Path for Clinical Translation.

Histologic Transformation in Cancer: The Path for Clinical Translation.

Journal: Cancer discovery

Published: December 20, 2024

Treatment Sequences in BRAF-V600-Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) Immunotherapy.

Treatment Sequences in BRAF-V600-Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) Immunotherapy.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 12, 2024

Perioperative Targeted Therapy for Operable, Early Stage NSCLC

Perioperative Targeted Therapy for Operable, Early Stage NSCLC

Journal: Zentralblatt fur Chirurgie

Published: August 13, 2024

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy.

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 12, 2024

Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome.

Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome.

Journal: International journal of cancer

Published: April 15, 2024

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Journal: International journal of molecular sciences

Published: February 26, 2024

Advanced non-small cell lung cancer - pioneer in personalized oncology

Advanced non-small cell lung cancer - pioneer in personalized oncology

Journal: Deutsche medizinische Wochenschrift (1946)

Published: September 01, 2023

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer.

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer.

Journal: Frontiers in oncology

Published: August 06, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026